Prot# 233AS102: An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB067 Administered to Previously Treated Adults with Amyotrophic Lateral Sclerosis Caused by Superoxide Dismutase 1 M

Project: Research project

Project Details

StatusActive
Effective start/end date11/24/20 → 9/30/25

Funding

  • Quintiles, Inc. (Prot# 233AS102 // Prot# 233AS102)
  • Biogen MA Inc. (Prot# 233AS102 // Prot# 233AS102)